In the early 2000s, it was confirmed that the blockade of Nav 1.6 by PHT diminished the activation, proliferation and/or phagocytosis of CD45+ cells, including microglia, and protected axons in an animal model of multiple sclerosis and experimental acute encephalomyelitis (EAE) [41,42,44]. Here, PTPRC is linked to multiple sclerosis.